Browsing Interface : Welcome guest : log in
|
Browsing Interface : Welcome guest : log in |
[
Home |
Graph |
LogLearn |
Editor |
]
KB:
Language:
Formal Language:
|
| Upadacitinib(upadacitinib) |
| appearance as argument number 1 |
|
| (subclass Upadacitinib Medicine) | Medicine.kif 5559-5559 | Upadacitinib is a subclass of medicine |
| (documentation Upadacitinib EnglishLanguage "Upadacitinib, sold under the brand name Rinvoq, is a Janus kinase (JAK) inhibitor medication for the treatment of moderately to severely active RheumatoidArthritis in adults where methotrexate (a drug used to treat active arthritis) did not work well or could not be tolerated. It was developed by the biotech company AbbVie. Common side effects include upper respiratory tract infections (common cold, sinus infections), Nausea, Cough, and Fever.[from Wikipedia]") | Medicine.kif 5561-5568 | Upadacitinib is a subclass of medicine |
| (diseaseMedicine Upadacitinib RheumatoidArthritis Ingesting) | Medicine.kif 5569-5569 | Upadacitinib is disease treatment rheumatoid arthritis for ingesting |
| (sideEffect Upadacitinib Nausea) | Medicine.kif 5570-5570 | Nausea is a side effect of taking upadacitinib |
| (sideEffect Upadacitinib Fever) | Medicine.kif 5571-5571 | A fever is a side effect of taking upadacitinib |
| appearance as argument number 2 |
|
|
| (termFormat EnglishLanguage Upadacitinib "upadacitinib") | Medicine.kif 5572-5572 | |
| (subclass Rinvoq Upadacitinib) | Medicine.kif 5574-5574 | Rinvoq is a subclass of upadacitinib |
|